BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 21898772)

  • 1. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
    Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
    Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and risk factors for late infection in solid organ transplant recipients.
    Cervera C; Fernández-Ruiz M; Valledor A; Linares L; Antón A; Ángeles Marcos M; Sanclemente G; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Pumarola T; Moreno A
    Transpl Infect Dis; 2011 Dec; 13(6):598-607. PubMed ID: 21535336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious complications after liver transplantation in human immunodeficiency virus-infected recipients.
    Teicher E; Boufassa F; Vittecoq D; Antonini TM; Tateo MG; Coilly A; Roque-Afonso AM; Kassis-Chikhani N; Lambotte O; Ichai P; Samuel D; Duclos-Vallee JC
    Transpl Infect Dis; 2015 Oct; 17(5):662-70. PubMed ID: 26192379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
    Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
    Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection.
    Lesens O; Deschênes M; Steben M; Bélanger G; Tsoukas CM
    J Infect Dis; 1999 May; 179(5):1254-8. PubMed ID: 10191232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007.
    Vellozzi C; Buchacz K; Baker R; Spradling PR; Richardson J; Moorman A; Tedaldi E; Durham M; Ward J; Brooks JT;
    J Viral Hepat; 2011 May; 18(5):316-24. PubMed ID: 20367803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol.
    Schuval S; Van Dyke RB; Lindsey JC; Palumbo P; Mofenson LM; Oleske JM; Cervia J; Kovacs A; Dankner WN; Smith E; Nowak B; Ciupak G; Webb N; Eagle M; Smith D; Hennessey R; Goodman-Kerkau M; Levin MJ;
    Arch Pediatr Adolesc Med; 2004 Oct; 158(10):1007-13. PubMed ID: 15466691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
    Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
    Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study.
    Gutiérrez-Moreno M; Bernal-Bellido C; Suárez-Artacho G; Alamo-Martínez JM; Marín-Gómez LM; Serrano-Díaz-Canedo J; Padillo-Ruiz FJ; Gómez-Bravo MA
    Transplant Proc; 2012 Sep; 44(7):2100-2. PubMed ID: 22974923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV recurrence in HIV-infected patients after liver transplant.
    Hughes CB; Dickson RC; Krishna M; Willingham DL; Satyanarayana R; Harnois DM; Keaveny AP; Rosser B; Aranda-Michel J; Kramer DJ; Hellinger W; Mendez J
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):87-93. PubMed ID: 20357036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
    Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
    J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
    Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
    Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.